Results 71 to 80 of about 25,219 (211)

Anomalous Origin of the Left Coronary System From the Right Coronary Cusp: A Case Report

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT The early recognition of this rare coronary anomaly using multiple imaging modalities such as CCTA provided invaluable information to better stratify the risk, clarify prognosis, and deliver the most appropriate intervention.
Cristian Castillo‐Rodriguez, Michel Juarez, Leighann Jenkins, Jason Wischmeyer, Sherif Roman, Prince Lemuel‐Ernest, Justin Price   +6 more
wiley   +1 more source

From Thrombolysis to Transplant: Navigating the Storm of Delayed STEMI and Cardiogenic Shock

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Delayed STEMI presentation can cause extensive myocardial necrosis, left ventricular thrombus, cardiogenic shock, and progression to end‐stage heart failure despite reperfusion. Early recognition and timely transfer to specialized shock centers are critical.
Syed Rafay Hussain Zaidi, Muhammad Sheraz Hameed, Muhammad Ahsan, Hamza Ishfaq, Ali Iqbal, Azka Mirza, Sadia Rekhum, Muhammad Sohaib Alvi, Muhammad Usama Naveed   +8 more
wiley   +1 more source

Apixaban and clopidogrel in a fixed-dose combination: Formulation and in vitro evaluation

Saudi Pharmaceutical Journal
Fixed-dose combination (FDC) products represent a novel, safe, and cost-effective formulation. Combined use of anticoagulant and antiplatelet medications is common among comorbid cardiovascular patients.
Ni'meh Al-Shami, Hani Naseef, Feras Kanaze   +2 more
doaj   +1 more source

Development and Optimization of Apixaban Loaded Solid Lipid Nanoparticles by Central Composite Design, in vitro and ex vivo Characterization

, 2022
Suresh Konatham, P. Shashikala
openalex   +2 more sources

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects

Clinical Pharmacology: Advances and Applications, 2017
Charles Frost,1 Yan Song,1 Zhigang Yu,2 Jessie Wang,3 Lois S Lee,4 Alan Schuster,5 Allyson Pollack,1 Frank LaCreta1 1Exploratory Clinical and Translational Research, Bristol-Myers Squibb, Princeton, NJ, USA; 2Medical Sciences, Amgen Asia R&D Center ...
Frost C, Song Y, Yu Z, Wang J, Lee LS, Schuster A, Pollack A, LaCreta F   +7 more
doaj  

Outcomes and Risk Factors in Oncologic Temporal Bone Surgery: A Head and Neck‐Specific NSQIP Analysis

Otolaryngology–Head and Neck Surgery, Volume 174, Issue 3, Page 774-783, March 2026.
Abstract Objective Advanced temporal bone and parotid gland malignancies are rare and difficult to manage. However, complications of oncologic temporal bone surgery have not been systematically categorized. We aim to detail the postoperative outcomes of lateral temporal bone resection (LTBR) and mastoidectomy for otologic oncology patients, and ...
Bailey H. Duhon, Xiaowen Sun, Mike Hernandez, Carol M. Lewis, Marc‐Elie Nader, Paul W. Gidley   +5 more
wiley   +1 more source

Bismuth Bicycles

Journal of Peptide Science, Volume 32, Issue 3, March 2026.
Discovery, evolution and potential future applications of bismuth bicycle molecules—a novel class of therapeutics with unique properties. ABSTRACT Bicyclic peptides are emerging as next generation therapeutics by combining the affinity and specificity of antibodies with the synthetic convenience of small molecules.
Saan Voss, Amin Sagar, Arnaud Tiberghien, Richard J. L. Hughes, Liuhong Chen, Inmaculada Rioja, Mark Frigerio, Michael J. Skynner, David R. Spring   +8 more
wiley   +1 more source

After the AUGUSTUS Trial, Should Apixaban Be the Only Direct Oral Anticoagulant to Be Used in Triple Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention? [PDF]

, 2019
Andrea Rubboli, Matteo Lisi
openalex   +1 more source

Same Session Validation of a Custom‐Built 22G With the Commercial 25G System for EUS‐Guided Portal Pressure Gradient Measurement

United European Gastroenterology Journal, Volume 14, Issue 2, March 2026.
ABSTRACT Background and Aims Endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG) measurement is a promising alternative to hepatic venous pressure gradient (HVPG) assessment, especially in settings where HVPG is unavailable or limited. The commercial 25‐gauge (25G) system showed good correlation with the hepatic venous pressure gradient ...
Michael Praktiknjo, Nancy Farouk, Zeyu Wang, Juliana Stadtmann, Dominik van de Loo, Markus Kimmann, Carina Gunia, Jörn Arne Meier, Frank Erhard Uschner, Kai‐Henrik Peiffer, Wim Laleman, Jonel Trebicka, Barbara Braden   +12 more
wiley   +1 more source

Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events [PDF]

, 2017
Gillian E. Caughey, Lisa Kalisch Ellett, John D. Barratt, Sepehr Shakib   +3 more
openalex   +1 more source